Revolutionary TULSA Procedure Transforms Prostate Disease Treatment Without Surgery
Revolutionary TULSA Procedure Transforms Prostate Disease Treatment Without Surgery
Revolutionary TULSA Procedure Transforms Prostate Disease Treatment Without Surgery
A medical device company called Profound Medical Corp. has developed an advanced therapy for prostate disease. Their TULSA Procedure uses robotically controlled ultrasound and real-time MRI to treat conditions like prostate cancer and benign prostatic hyperplasia (BPH). The technology is now being adopted by more clinics, with one US centre recently reaching a major milestone.
The procedure avoids incisions and relies on AI-powered MRI guidance to target diseased tissue while sparing healthy areas. It has gained approval across key global markets and is expanding in the US, where demand is growing rapidly. The TULSA Procedure works by heating prostate tissue to a precise 'kill temperature' of 55–57°C. Unlike older methods, it uses directional ultrasound and continuous MRI thermography to monitor and adjust heat levels in real time. This protects surrounding nerves and anatomy, reducing side effects.
Profound Medical Corp. has installed 78 TULSA-PRO systems worldwide as of December 2025, with plans to reach 120 by the end of 2026. Major US clinics, including Texas Prostate Institute in Dallas and Mount Sinai Hospital in New York, now offer the treatment. One of the leading adopters, Texas Prostate, recently completed its 100th procedure at Dallas Medical Center's MRI suite.
Dr. James Cochran, who leads Texas Prostate, shifted his practice to focus on TULSA after seeing its advantages over alternatives like HIFU. The procedure's broader range of applications and improved safety profile convinced him to make the switch. His clinic's move to a Medicare-based model with Dallas Medical Center also boosted procedure numbers by 500%.
Profound Medical Corp. recognised Dr. Cochran's team for reaching the 100-procedure mark. The company highlights the technology's precision, which comes from in-bore MRI visualization during treatment. This allows for more accurate and safer therapy compared to traditional methods. The TULSA Procedure is now available at leading US and international clinics, with adoption rates climbing. Profound Medical Corp.'s global expansion continues, supported by its growing installed base of systems. The technology's ability to treat multiple prostate conditions with fewer risks has driven its uptake among specialists like Dr. Cochran.